{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:33:15Z","timestamp":1791235995047,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":3408,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1017\/s1041610215000447","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T08:48:07Z","timestamp":1436863687000},"page":"1429-1438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Use of CSF \u03b1-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders"],"prefix":"10.1016","volume":"27","author":[{"given":"Zheng-Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Min","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-You","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610215000447_bb0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00401-006-0104-6","article-title":"Alpha-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers","volume":"112","author":"Beyer","year":"2006","journal-title":"Acta Neuropathologica"},{"key":"10.1017\/S1041610215000447_bb0015","first-page":"221","article-title":"Low frequency of post-lumbar puncture headache in demented patients","volume":"88","author":"Blennow","year":"1993","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1017\/S1041610215000447_bb0020","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0166-2236(94)90013-2","article-title":"Synuclein proteins and Alzheimer's disease","volume":"17","author":"Brookes","year":"1994","journal-title":"Trends in Neurosciences"},{"key":"10.1017\/S1041610215000447_bb0025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0888-7543(95)80237-G","article-title":"The human NACP\/alpha-synuclein gene: chromosome assignment to 4q21.3-q22 and TaqI RFLP analysis","volume":"26","author":"Chen","year":"1995","journal-title":"Genomics"},{"key":"10.1017\/S1041610215000447_bb0030","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0002-9440(10)65220-0","article-title":"Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid","volume":"155","author":"Culvenor","year":"1999","journal-title":"The American Journal of Pathology"},{"key":"10.1017\/S1041610215000447_bb0035","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"British Medical Journal"},{"key":"10.1017\/S1041610215000447_bb0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1353-8020(08)70049-X","article-title":"Treatment of dementia associated with Parkinson's disease","volume":"13","author":"Emre","year":"2007","journal-title":"Parkinsonism and Related Disorders"},{"key":"10.1017\/S1041610215000447_bb0045","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nbd.2007.01.014","article-title":"Alpha-synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton","volume":"26","author":"Esposito","year":"2007","journal-title":"Neurobiology of Disease"},{"key":"10.1017\/S1041610215000447_bb0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jcp.20602","article-title":"Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease","volume":"208","author":"Formichi","year":"2006","journal-title":"Journal of Cellular Physiology"},{"key":"10.1017\/S1041610215000447_bb0055","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0896-6273(95)90040-3","article-title":"Characterization of a novel protein regulated during the critical period for song learning in the zebra finch","volume":"15","author":"George","year":"1995","journal-title":"Neuron"},{"key":"10.1017\/S1041610215000447_bb0060","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1098\/rstb.1999.0466","article-title":"Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies","volume":"354","author":"Goedert","year":"1999","journal-title":"Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences"},{"key":"10.1017\/S1041610215000447_bb0065","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","article-title":"DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease","volume":"133","author":"Hong","year":"2010","journal-title":"Brain"},{"key":"10.1017\/S1041610215000447_bb0070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00005072-199608000-00004","article-title":"Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system","volume":"55","author":"Irizarry","year":"1996","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1017\/S1041610215000447_bb0075","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.23659","article-title":"Neuropathologic substrates of Parkinson disease dementia","volume":"72","author":"Irwin","year":"2012","journal-title":"Annals of Neurology"},{"key":"10.1017\/S1041610215000447_bb0080","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"key":"10.1017\/S1041610215000447_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-5793(94)00395-5","article-title":"Identification of two distinct synucleins from human brain","volume":"345","author":"Jakes","year":"1994","journal-title":"FEBS Letters"},{"key":"10.1017\/S1041610215000447_bb0090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00401-008-0347-5","article-title":"Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease","volume":"115","author":"Jellinger","year":"2008","journal-title":"Acta Neuropathologica"},{"key":"10.1017\/S1041610215000447_bb0095","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.1016\/j.neurobiolaging.2011.02.018","article-title":"Preclinical AD workgroup staging: pathological correlates and potential challenges","volume":"33","author":"Jicha","year":"2012","journal-title":"Neurobiology of Aging"},{"key":"10.1017\/S1041610215000447_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-2999(01)00902-5","article-title":"Release and aggregation of cytochrome c and alpha-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole","volume":"417","author":"Kakimura","year":"2001","journal-title":"European Journal of Pharmacology"},{"key":"10.1017\/S1041610215000447_bb0105","doi-asserted-by":"crossref","first-page":"e81654","DOI":"10.1371\/journal.pone.0081654","article-title":"The diagnostic value of CSF alpha-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer's disease","volume":"8","author":"Kapaki","year":"2013","journal-title":"PloS One"},{"key":"10.1017\/S1041610215000447_bb0110","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jnnp.2009.197483","article-title":"Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease","volume":"81","author":"Kasuga","year":"2010","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1017\/S1041610215000447_bb0115","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1046\/j.1471-4159.1999.0732586.x","article-title":"Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury","volume":"73","author":"Kholodilov","year":"1999","journal-title":"Journal of Neurochemistry"},{"key":"10.1017\/S1041610215000447_bb0120","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1101\/gr.8.9.871","article-title":"The synuclein family","volume":"8","author":"Lavedan","year":"1998","journal-title":"Genome Research"},{"issue":"Suppl. 6","key":"10.1017\/S1041610215000447_bb0125","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/mds.10559","article-title":"Clinical overview of the synucleinopathies","volume":"18","author":"Marti","year":"2003","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"key":"10.1017\/S1041610215000447_bb0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.31887\/DCNS.2004.6.3\/imckeith","article-title":"Dementia with Lewy bodies","volume":"6","author":"McKeith","year":"2004","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"10.1017\/S1041610215000447_bb0135","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/ana.410440715","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"44","author":"Mizuno","year":"1998","journal-title":"Annals of Neurology"},{"key":"10.1017\/S1041610215000447_bb0140","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000083178","article-title":"Tau protein, abeta 42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies","volume":"19","author":"Mollenhauer","year":"2005","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1017\/S1041610215000447_bb0145","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","article-title":"Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration","volume":"213","author":"Mollenhauer","year":"2008","journal-title":"Experimental Neurology"},{"key":"10.1017\/S1041610215000447_bb0150","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","article-title":"Alpha-synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study","volume":"10","author":"Mollenhauer","year":"2011","journal-title":"Lancet Neurology"},{"key":"10.1017\/S1041610215000447_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2008.11.055","article-title":"CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease","volume":"1251","author":"Noguchi-Shinohara","year":"2009","journal-title":"Brain Research"},{"key":"10.1017\/S1041610215000447_bb0160","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1523\/JNEUROSCI.19-14-05782.1999","article-title":"Alpha-synuclein shares physical and functional homology with 14-3-3 proteins","volume":"19","author":"Ostrerova","year":"1999","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"key":"10.1017\/S1041610215000447_bb0165","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/mds.23670","article-title":"Cerebrospinal fluid Tau\/alpha-synuclein ratio in Parkinson's disease and degenerative dementias","volume":"26","author":"Parnetti","year":"2011","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"key":"10.1017\/S1041610215000447_bb0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s100720170055","article-title":"Phospho-tau international study group. CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies, phospho-tau international study group","volume":"22","author":"Parnetti","year":"2001","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1017\/S1041610215000447_bb0175","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archneurol.2009.266","article-title":"Mild cognitive impairment: ten years later","volume":"66","author":"Petersen","year":"2009","journal-title":"Archives of Neurology"},{"key":"10.1017\/S1041610215000447_bb0180","first-page":"703","article-title":"Early diagnosis of dementia","volume":"63","author":"Santacruz","year":"2001","journal-title":"American Family Physician"},{"key":"10.1017\/S1041610215000447_bb0185","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.22311","article-title":"Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression","volume":"69","author":"Shi","year":"2011","journal-title":"Annals of Neurology"},{"key":"10.1017\/S1041610215000447_bb0190","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0014-5793(00)01563-5","article-title":"Chaperone-like activity of synucleins","volume":"474","author":"Souza","year":"2000","journal-title":"FEBS Letters"},{"key":"10.1017\/S1041610215000447_bb0195","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3233\/JAD-2009-0955","article-title":"Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders","volume":"16","author":"Spies","year":"2009","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1017\/S1041610215000447_bb0200","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/geno.1995.1063","article-title":"Assignment of human alpha-synuclein (SNCA) and beta-synuclein (SNCB) genes to chromosomes 4q21 and 5q35","volume":"27","author":"Spillantini","year":"1995","journal-title":"Genomics"},{"key":"10.1017\/S1041610215000447_bb0205","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1046\/j.1471-4159.2001.00114.x","article-title":"Synuclein-1 is selectively up-regulated in response to nerve growth factor treatment in PC12 cells","volume":"76","author":"Stefanis","year":"2001","journal-title":"Journal of Neurochemistry"},{"key":"10.1017\/S1041610215000447_bb0210","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ajpath.2013.12.007","article-title":"Cerebrospinal fluida-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort","volume":"184","author":"Stewart","year":"2014","journal-title":"The American Journal of Pathology"},{"key":"10.1017\/S1041610215000447_bb0215","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00702-014-1226-y","article-title":"Does CSF p-tau181 help to discriminate Alzheimer's disease from other dementias and mild cognitive impairment? A meta-analysis of the literature","volume":"121","author":"Tang","year":"2014","journal-title":"Journal of Neural Transmission"},{"key":"10.1017\/S1041610215000447_bb0220","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2014.07.015","article-title":"Does CSF A\u03b242 as an aid to discriminating Alzheimer's disease from other dementias and mild cognitive impairment: a meta-analysis of 50 studies","volume":"345","author":"Tang","year":"2014","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1017\/S1041610215000447_bb0225","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/WAD.0b013e31823899cc","article-title":"Alpha-synuclein in the cerebrospinal fluid differentiates synucleinopathies (Parkinson disease, dementia with Lewy bodies, multiple system atrophy) from Alzheimer disease","volume":"26","author":"Tateno","year":"2012","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1017\/S1041610215000447_bb0230","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","article-title":"Detection of elevated levels of \u03b1-synuclein oligomers in CSF from patients with Parkinson disease","volume":"75","author":"Tokuda","year":"2010","journal-title":"Neurology"},{"key":"10.1017\/S1041610215000447_bb0235","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","article-title":"Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease","volume":"90","author":"Ueda","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1017\/S1041610215000447_bb0240","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1523\/JNEUROSCI.20-16-06021.2000","article-title":"Neuropathology in mice expressing human alpha-synuclein","volume":"20","author":"van der Putten","year":"2000","journal-title":"The Journal of Neuroscience: the Official Journal of the Society for Neuroscience"},{"key":"10.1017\/S1041610215000447_bb0245","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/JAD-2012-111655","article-title":"Altered CSF orexin and alpha-synuclein levels in dementia patients","volume":"29","author":"Wennstrom","year":"2012","journal-title":"Journal of Alzheimer's disease"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224007063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224007063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610215000447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T13:14:12Z","timestamp":1736514852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224007063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1041610224007063"],"URL":"https:\/\/doi.org\/10.1017\/s1041610215000447","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of CSF \u03b1-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610215000447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}